NeoVascularX Revenue
Biotechnology Research • 
Palo Alto, California, United States • 1-10 Employees
$
NeoVascularX revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at NeoVascularX
Hiro Serizawa
CEO
Company overview
| Headquarters | 3000 El Camino Real, Building 4, Suite 200, Palo Alto, CA 94306, US |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
About NeoVascularX
Clinical development of topical ophthalmic products for neovascular Age-related Macular Degeneration (nAMD)
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
NeoVascularX has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
NeoVascularX has never raised funding before.
France
Taiwan, Province of China
Australia
CanadaFrequently asked questions
NeoVascularX is located in Palo Alto, California, US.
NeoVascularX generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
NeoVascularX has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
NeoVascularX was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
NeoVascularX has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
